FDA clears Beckman Coulter's automated microplate system for blood banking

LabPulse.com staff writers
Jul 22, 2020
2019 08 09 22 20 6739 Beckman Coulter Aacc 2019 400

Beckman Coulter has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its automated microplate system and associated reagents.

The PK7400 system is a high-throughput single analyzer designed for large laboratories and blood donor and plasma centers. It can process up to 300 samples per hour, the company noted.

The automated microplate system uses prosperity liquid and readymade regents. Users can run up to 12 tests per sample, including ABO blood grouping, Rh typing, weak D testing, Rh-Kell phenotyping, and syphilis screening.

Latest in Syphilis
Fda Sign Dc Social
NowDiagnostics submits FDA de novo request for OTC syphilis test
January 10, 2024
Hiv Virions Cdc Social
Biolytical Laboratories nabs Health Canada authorization for HIV-1/2 syphilis antibody test
March 27, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
2022 09 06 18 59 7755 Blood Cells Vessel2 400
CDC awards Chembio $3.2M for development of syphilis POC test
September 5, 2022
Related Stories
2022 06 09 18 00 5852 Lab Blood Samples 400
Consumer
Blood grouping, typing market estimated at $945 million
2019 08 09 22 20 6739 Beckman Coulter Aacc 2019 400
Emergency Use Authorization
Beckman Coulter launches new COVID-19 IgG test
2019 08 09 22 20 6739 Beckman Coulter Aacc 2019 400
Emergency Use Authorization
Beckman Coulter launches high-throughput COVID-19 assay
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Syphilis
NowDiagnostics submits FDA de novo request for OTC syphilis test
By LabPulse.com staff writers
NowDiagnostics has submitted a de novo authorization request to the U.S. Food and Drug Administration (FDA) for its First to Know over-the-counter (OTC) syphilis test.
January 10, 2024
Fda Sign Dc Social
Biolytical Laboratories nabs Health Canada authorization for HIV-1/2 syphilis antibody test
By LabPulse.com staff writers
The test detects HIV-1, HIV-2, and syphilis antibodies using a sample and fingerprick, delivering results in one minute or less.
March 27, 2023
Hiv Virions Cdc Social
Chembio Diagnostics obtains FDA CLIA waiver for HIV-syphilis testing system
By LabPulse.com staff writers
More than 200,000 CLIA-waived point-of-care testing sites in the U.S. can now use the system to detect HIV and syphilis, Richard Eberly, Chembio’s president and CEO, said in a statement.
February 24, 2023
Hiv Virions Cdc Social
CDC awards Chembio $3.2M for development of syphilis POC test
By LabPulse.com staff writers
Under the contract, Chembio will develop a syphilis test and confirm assay based on its Dual Path Platform (DPP) technology and DPP Micro Reader II. The assay will be designed to simultaneously and separately detect treponemal and nontreponemal IgM and IgG antibodies.
September 5, 2022
2022 09 06 18 59 7755 Blood Cells Vessel2 400
FDA reports syphilis testing kit may generate false positives
By LabPulse.com staff writers
The FDA said false-positive results have been observed in some individuals for at least five months following vaccination.
December 20, 2021
2021 11 29 23 50 3003 Fda Button 20211129235739
COVID-19 highlights need for at-home STI testing
By Leah Sherwood
It has been widely reported that the COVID-19 pandemic has caused declines in rates for different screening exams, and the same holds for STI screenings, according to the authors, led by Ellen Kersh, PhD, of the U.S. Centers for Disease Control and Prevention (CDC).
October 25, 2021
2020 03 10 00 02 9515 Delivery Package Box 400
Thermo Fisher debuts infectious disease quality controls
By LabPulse.com staff writers
The Thermo Scientific Mas Omni Infectious positive and negative quality controls are third-party, independent external controls used to assess the performance of serological assays for HIV types 1 and 2, hepatitis B and C, syphilis, and human T-cell leukemia virus types 1 and 2. Monitoring the assays' performance can streamline operations and may reduce spending without sacrificing quality, according to the company.
June 30, 2020
2020 07 01 16 59 5154 Thermo Fisher Qualitycontrol 400
STD test market grows with incidence, new tech
By Bruce Carlson
Not that long ago, rates of gonorrhea infection were at historically low levels, and elimination of syphilis was a reasonable goal. The diagnostics industry was able to highlight how advances in STD detection and prevention brought increased rates of detection and treatment.
May 27, 2019
2019 02 14 22 43 9283 Carlson Bruce 20190524200814
Page 1 of 1